| Inbound Relationships | 
Type | 
Active | 
Source | 
Characteristic | 
Refinability | 
Group | 
| Turbidity test, quantitative | 
Scale type | 
False | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
  | 
| Lead measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 1 | 
| Lead measurement, quantitative, urine | 
Scale type | 
False | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
  | 
| Lead measurement, quantitative, blood | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| 24 hour urine lead output | 
Scale type | 
False | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
  | 
| Fecal fat measurement, 24-hour collection | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 1 | 
| Carboxyhemoglobin measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Lactose measurement, urine, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of ketone in serum specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of amino acid in cerebrospinal fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Porphobilinogen measurement, quantitative, urine | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Chemical test, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 2 | 
| Quantitative measurement of cystine in random urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Phenothiazine measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Hemosiderin, quantitative measurement | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Morphine measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| 5-Hydroxyindoleacetic acid measurement, quantitative, urine | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mercaptopurine | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| 24 hour urine 3-methoxytyramine output | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of polychlorinated biphenyl in blood specimen using gas chromatography | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Cystine measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Quantitative measurement of lysergic acid diethylamide in urine specimen using high performance liquid chromatography | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Porphyrin, quantitative measurement, urine | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Albumin measurement, urine, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Stool fat, quantitative measurement | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of tricyclic antidepressant in serum specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of opiate agonist | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Urobilinogen measurement, timed urine specimen, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Febrile agglutinins, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 2 | 
| Hemoquant feces | 
Scale type | 
False | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
  | 
| Quantitative measurement of acylcarnitine in plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Porphyrin measurement, feces, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Glucose-6-phosphate dehydrogenase measurement, quantitative | 
Scale type | 
False | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
  | 
| Quantitative measurement of amino acid in urine | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Ketone bodies measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Barbiturates measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Quantitative measurement of acylcarnitine in blood specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| 24 hour urine porphobilinogen output | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Quantitative measurement of cannabinoids | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| 24 hour urine cystine output measurement | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Methemoglobin measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Quantitative measurement of mass concentration of immunoglobulin M in serum specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Acid mucopolysaccharides measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Quantitative measurement of mass concentration of immunoglobulin G in cord blood specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of 6-monoacetylmorphine in saliva specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of bismuth in urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of barbiturate in urine specimen using gas chromatography mass spectrometry technique | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of substance ratio of free deoxypyridinoline relative to creatinine in urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of glucose in first peritoneal dialysis fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass content of calprotectin in stool specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of concentration of cryoglobulin in serum specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of immunoglobulin G in serum specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Glucose measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Quantitative measurement of mass concentration of nordazepam in saliva specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of mephenytoin and normephenytoin in serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of immunoglobulin M in cerebrospinal fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of albumin in serum or plasma specimen using bromcresol green technique | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of hydrocortisone in serum or plasma specimen obtained at a specified time | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of creatinine in peritoneal fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of 7-aminonitrazepam in saliva specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass concentration of immunoglobulin G in body fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of creatinine in postdialysis serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Calculation of quantitative volume rate of glomerular filtration based on creatinine concentration in serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass concentration of creatinine in 2 hour postperitoneal dialysis fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass concentration of ethylene glycol in urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of prostate specific antigen in serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of benzodiazepine in urine specimen using gas chromatography mass spectrometry technique | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass concentration of glucose in predialysis peritoneal dialysis fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of concentration of follitropin in baseline serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of substance ratio of collagen cross linked N-telopeptide in relation to creatinine in 24 hour urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of substance rate of glucose excretion in urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of creatinine in serum or plasma specimen using colorimetric enzyme technique | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass rate of excretion of creatinine in timed urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of substance fraction of oxygen relative to oxygen binding sites of hemoglobin in venous blood specimen | 
Scale type | 
False | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
  | 
| Quantitative measurement of mass concentration ratio of excretion of chromium to excretion of creatinine in 24 hour urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of fluoride in urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of flurazepam in urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of dihydrocodeine in saliva specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of ciclosporin in serum or plasma specimen using enzyme immunoassay technique | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of histamine in serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of immunoglobulin M in cord blood specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of oxcarbazepine in serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Heavy metal measurement, quantitative | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 3 | 
| Quantitative measurement of mass concentration of benzoylecgonine in serum or plasma specimen using gas chromatography mass spectrometry technique | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass concentration of 11-deoxycortisol in urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of creatinine in 4 hour postperitoneal dialysis fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass rate of excretion of pyridinoline in 2 hour urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of substance rate ratio of pyridinoline to creatinine in 24 hour urine specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Calculation of quantitative volume rate of glomerular filtration based on cystatin C concentration in serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass concentration of hydrocortisone in p.m. serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of glucose in pericardial fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of cannabinoids in urine specimen using gas chromatography mass spectrometry technique | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass concentration of temazepam in saliva specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of immunoglobulin A in cord blood specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of flurazepam and flurazepam metabolite in serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass concentration of dextropropoxyphene in serum or plasma specimen using gas chromatography mass spectrometry technique | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Calculation of quantitative volume rate of glomerular filtration based on concentration of analyte in serum or plasma specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 4 | 
| Quantitative measurement of mass concentration of immunoglobulin M in body fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of phencyclidine in serum or plasma specimen using gas chromatography mass spectrometry technique | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of codeine in saliva specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 | 
| Quantitative measurement of mass concentration of creatinine corrected for glucose concentration in overnight peritoneal dialysis fluid specimen | 
Scale type | 
True | 
Quantitative | 
Inferred relationship | 
Existential restriction modifier | 
 5 |